Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2014 1
2018 2
2020 1
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH.
Maeda H, Ishima Y, Saruwatari J, Mizuta Y, Minayoshi Y, Ichimizu S, Yanagisawa H, Nagasaki T, Yasuda K, Oshiro S, Taura M, McConnell MJ, Oniki K, Sonoda K, Wakayama T, Kinoshita M, Shuto T, Kai H, Tanaka M, Sasaki Y, Iwakiri Y, Otagiri M, Watanabe H, Maruyama T. Maeda H, et al. Among authors: yanagisawa h. J Control Release. 2022 Jan;341:457-474. doi: 10.1016/j.jconrel.2021.11.039. Epub 2021 Nov 29. J Control Release. 2022. PMID: 34856227
A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease.
Nagasaki T, Maeda H, Taguchi K, Yanagisawa H, Nishida K, Kobayashi K, Wada N, Noguchi I, Murata R, Sakai H, Kitagishi H, Saruwatari J, Watanabe H, Otagiri M, Maruyama T. Nagasaki T, et al. Among authors: yanagisawa h. Redox Biol. 2022 Aug;54:102371. doi: 10.1016/j.redox.2022.102371. Epub 2022 Jun 22. Redox Biol. 2022. PMID: 35763935 Free PMC article.
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment.
Noguchi I, Maeda H, Kobayashi K, Nagasaki T, Kato H, Yanagisawa H, Wada N, Kanazawa G, Kaji T, Sakai H, Fujimaki S, Ono Y, Taguchi K, Chuang VTG, Saruwatari J, Otagiri M, Watanabe H, Maruyama T. Noguchi I, et al. Among authors: yanagisawa h. Free Radic Biol Med. 2024 Apr 23;220:67-77. doi: 10.1016/j.freeradbiomed.2024.04.231. Online ahead of print. Free Radic Biol Med. 2024. PMID: 38657755
Carbon Monoxide Rescues the Developmental Lethality of Experimental Rat Models of Rhabdomyolysis-Induced Acute Kidney Injury.
Taguchi K, Ogaki S, Nagasaki T, Yanagisawa H, Nishida K, Maeda H, Enoki Y, Matsumoto K, Sekijima H, Ooi K, Ishima Y, Watanabe H, Fukagawa M, Otagiri M, Maruyama T. Taguchi K, et al. Among authors: yanagisawa h. J Pharmacol Exp Ther. 2020 Mar;372(3):355-365. doi: 10.1124/jpet.119.262485. Epub 2020 Jan 10. J Pharmacol Exp Ther. 2020. PMID: 31924689
Evaluation of artificial intelligence systems for assisting neurologists with fast and accurate annotations of scalp electroencephalography data.
Roy S, Kiral I, Mirmomeni M, Mummert T, Braz A, Tsay J, Tang J, Asif U, Schaffter T, Ahsen ME, Iwamori T, Yanagisawa H, Poonawala H, Madan P, Qin Y, Picone J, Obeid I, Marques BA, Maetschke S, Khalaf R, Rosen-Zvi M, Stolovitzky G, Harrer S; IBM Epilepsy Consortium. Roy S, et al. Among authors: yanagisawa h. EBioMedicine. 2021 Apr;66:103275. doi: 10.1016/j.ebiom.2021.103275. Epub 2021 Mar 18. EBioMedicine. 2021. PMID: 33745882 Free PMC article.
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.
Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T. Minayoshi Y, et al. Among authors: yanagisawa h. Drug Deliv. 2018 Nov;25(1):1067-1077. doi: 10.1080/10717544.2018.1464083. Drug Deliv. 2018. PMID: 29688069 Free PMC article.
12 results